Literature DB >> 2066158

The irritable bowel syndrome.

D L Wingate1.   

Abstract

The irritable bowel syndrome (IBS) is a familiar problem in the clinic, but as a disease entity it remains ill defined. Much confusion has arisen in the past, because of the inappropriate inclusion within the category of IBS of almost any patient with unexplained abdominal discomfort. Recent work has established that IBS patients can be positively identified by a cluster of specific symptoms. With the use of these criteria, it seems likely that IBS patients suffer from a diffuse motor abnormality of the gut associated with visceral hypersensitivity; although there is no associated psychopathology, a central nervous system component to the disorder is possible. Better insight into IBS promises more effective management.

Entities:  

Mesh:

Year:  1991        PMID: 2066158

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  3 in total

1.  Gut pain & visceral hypersensitivity.

Authors:  Adam D Farmer; Qasim Aziz
Journal:  Br J Pain       Date:  2013-02

Review 2.  Mood disorders and chronic obstructive pulmonary disease: current research and future needs.

Authors:  Greg L Clary; Scott M Palmer; P Murali Doraiswamy
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

3.  Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study.

Authors:  M Dapoigny; J L Abitbol; B Fraitag
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.